Ameriprise
RXII

Ameriprise’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Ameriprise’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-35,149
Closed -$12K – 4043
2016
Q3 		$12K Buy
35,149
+1,139
+3% +$389 ﹤0.01% 3751
2016
Q2 		$16K Sell
34,010
-1,000
-3% -$470 ﹤0.01% 3726
2016
Q1 		$48K Buy
35,010
+6
+0% +$8 ﹤0.01% 3680
2015
Q4 		$51K Sell
35,004
-2,056
-6% -$3K ﹤0.01% 3790
2015
Q3 		$58K Buy
37,060
+810
+2% +$1.27K ﹤0.01% 3766
2015
Q2 		$62K Sell
36,250
-960
-3% -$1.64K ﹤0.01% 3948
2015
Q1 		$52K Sell
37,210
-2,910
-7% -$4.07K ﹤0.01% 3724
2014
Q4 		$61K Buy
40,120
+5,721
+17% +$8.7K ﹤0.01% 3621
2014
Q3 		$71K Buy
34,399
+26,861
+356% +$55.4K ﹤0.01% 3836
2014
Q2 		$23K Buy
7,538
+7,140
+1,794% +$21.8K ﹤0.01% 4279
2014
Q1 		$1K Buy
398
+349
+712% +$877 ﹤0.01% 5260
2013
Q4 		$0 Sell
49
-5,203
-99% – ﹤0.01% 5853
2013
Q3 		$12K Hold
5,252
– – ﹤0.01% 4819
2013
Q2 		$12K Buy
+5,252
New +$12K ﹤0.01% 4686

Ameriprise's RXII Position: Q4 2016 in Review

Ameriprise sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 35,149 shares — an estimated $12K sold.

Ameriprise first reported a position in RXII in Q2 2013 and held it in 14 quarters. The position peaked at $71K in Q3 2014. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

  • Ameriprise reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
  • Ameriprise sold 35,149 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $12K.
  • Ameriprise first reported a position in GALENA BIOPHARMA INC COM in Q2 2013 and held it in 14 quarters.
  • Ameriprise's GALENA BIOPHARMA INC COM position peaked at $71K in Q3 2014.
  • 0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on Ameriprise's 13F filing for Q4 2016, filed 3 Feb 2017.